BioCentury | Dec 5, 2017
Distillery Therapeutics

Neurology

...S. et al. Nat. Commun. ; published online Nov. 14, 2017 doi:10.1038/s41467-017-01563-8 CONTACT: Shichun Tu, Scintillon Institute...
BioCentury | Nov 17, 2017
Preclinical News

Memantine-based NMDA receptor antagonist could help treat autism

...to autism disorders, however the molecular mechanism was unknown. In the current study, researchers at Scintillon Institute...
...his team suggest that NitroSynapsin could also help treat AD by correcting the E/I imbalance. Jennie Walters Scintillon Institute Myocyte...
BioCentury | Dec 14, 2016
Distillery Therapeutics

Neurology

...Natl. Acad. Sci. USA ; published online Nov. 7, 2016 doi:10.1073/pnas.1608784113 CONTACT: Stuart A. Lipton, Scintillon Institute...
Items per page:
1 - 3 of 3
BioCentury | Dec 5, 2017
Distillery Therapeutics

Neurology

...S. et al. Nat. Commun. ; published online Nov. 14, 2017 doi:10.1038/s41467-017-01563-8 CONTACT: Shichun Tu, Scintillon Institute...
BioCentury | Nov 17, 2017
Preclinical News

Memantine-based NMDA receptor antagonist could help treat autism

...to autism disorders, however the molecular mechanism was unknown. In the current study, researchers at Scintillon Institute...
...his team suggest that NitroSynapsin could also help treat AD by correcting the E/I imbalance. Jennie Walters Scintillon Institute Myocyte...
BioCentury | Dec 14, 2016
Distillery Therapeutics

Neurology

...Natl. Acad. Sci. USA ; published online Nov. 7, 2016 doi:10.1073/pnas.1608784113 CONTACT: Stuart A. Lipton, Scintillon Institute...
Items per page:
1 - 3 of 3